Release Date: 30/04/13 10:44 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 141.82KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%